Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - TITAN PHARMACEUTICALS INC | d238298d10k.htm |
| EX-32.1 - CERTIFICATE OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO SECTION 906 - TITAN PHARMACEUTICALS INC | d238298dex321.htm |
| EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO RULE 13(A)-14(A) - TITAN PHARMACEUTICALS INC | d238298dex311.htm |
| EX-4.7 - AMENDMENT NO. 1 TO RIGHTS AGREEMENT - TITAN PHARMACEUTICALS INC | d238298dex47.htm |
| EXCEL - IDEA: XBRL DOCUMENT - TITAN PHARMACEUTICALS INC | Financial_Report.xls |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-171181) and Form S-3 (File Nos. 333-178656 and 333-173457) of our reports dated March 14, 2012 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of Titan Pharmaceuticals, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2011.
/s/ OUM & Co. LLP
San Francisco, California
March 14, 2012